{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:08:39Z","timestamp":1787807319604,"version":"build-2784847793"},"reference-count":18,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"unspecified","delay-in-days":27,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNS Spectr."],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>Assisted Outpatient Treatment (AOT) is a controversial civil court program wherein a judge orders a person with severe mental illness to adhere to an outpatient treatment plan designed to improve treatment adherence, prevent relapse and dangerous deterioration. Several states, including California and New York, have recently promoted use of AOT to try to address high rates of homelessness among person with severe mental illness. Under AOT, clinicians treating these patients must balance the ethical principles of patient autonomy and beneficence, and employ AOT only when previous treatment failed as a result of treatment non-adherence. However, some critics of AOT argue that not only is it coercive and ineffective but that the court mandate to adhere to prescribed medications, usually antipsychotic medications, compels AOT recipients to take ineffective and even harmful medications. This article examines the assertion of these critics and reviews the evidence of antipsychotic effectiveness and potential harms in treating psychotic disorders under a civil court order.<\/jats:p>","DOI":"10.1017\/s1092852925000045","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T01:56:31Z","timestamp":1738029391000},"source":"Crossref","is-referenced-by-count":2,"title":["Assisted outpatient treatment: are court-ordered antipsychotic medications effective?"],"prefix":"10.1017","volume":"30","author":[{"given":"Sophia","family":"Kocher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1111-9299","authenticated-orcid":false,"given":"Marvin","family":"Swartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"S1092852925000045_r5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/0706743716675857","article-title":"Involuntary outpatient commitment and the elusive pursuit of violence prevention","volume":"62","author":"Swartz","year":"2017","journal-title":"Can J Psychiatry"},{"key":"S1092852925000045_r15","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S1516-44462011000200005","article-title":"The effectiveness of a non-pharmacological intervention for weight gain management in severe mental disorders: results from a national multicentric study","volume":"33","author":"Attux","year":"2011","journal-title":"Braz J Psychiatry"},{"key":"S1092852925000045_r16","first-page":"43","article-title":"Pharmacological treatment of severe dyslipidaemia in patients with schizophrenia","volume":"22","author":"Hanssens","year":"2007","journal-title":"Int Clin Psychopharmacol"},{"key":"S1092852925000045_r11","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.2017.16121358","article-title":". Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, bayesian meta-analysis, and meta-regression of efficacy predictors","volume":"174","author":"Leucht","year":"2017","journal-title":"Am J Psychiatry"},{"key":"S1092852925000045_r13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4088\/JCP.v67n0317","article-title":"Medication adherence and long-term functional outcomes in the treatment of schizophrenia in usual care","volume":"67","author":"Ascher-Svanum","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"S1092852925000045_r14","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/0269881114562090","article-title":"First do no harm.\u201d A systematic review of the prevalence and management of antipsychotic adverse effects","volume":"29","author":"Young","year":"2015","journal-title":"J Psychopharmacol"},{"key":"S1092852925000045_r17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-244X-7-28","article-title":"A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients","volume":"7","author":"Mackin","year":"2007","journal-title":"BMC Psychiatry"},{"key":"S1092852925000045_r12","first-page":"CD008016","article-title":"Maintenance treatment with antipsychotic drugs for schizophrenia","volume":"8","author":"Ceraso","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"S1092852925000045_r18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1192\/bjp.bp.106.031716","article-title":"Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community","volume":"191","author":"Mackin","year":"2007","journal-title":"Br J Psychiatry"},{"key":"S1092852925000045_r10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1176\/appi.ps.201600066","article-title":"Ethics of coercive treatment and misuse of psychiatry","volume":"68","author":"Steinert","year":"2017","journal-title":"Psychiatr Serv"},{"key":"S1092852925000045_r6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1176\/appi.ps.201300424","article-title":"Why the evidence for outpatient commitment is good enough","volume":"65","author":"Swanson","year":"2014","journal-title":"Psychiatr Serv"},{"key":"S1092852925000045_r1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s11920-018-0982-z","article-title":"Update on assisted outpatient treatment","volume":"20","author":"Cripps","year":"2018","journal-title":"Curr Psychiatry Rep"},{"key":"S1092852925000045_r9","doi-asserted-by":"crossref","first-page":"113118","DOI":"10.1016\/j.psychres.2020.113118","article-title":"The problem of medical-psychiatric illness in the homeless and its occurrence in the midst of a viral pandemic: a commentary","volume":"290","author":"Glick","year":"2020","journal-title":"Psychiatry Res"},{"key":"S1092852925000045_r2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1176\/ps.2010.61.2.137","article-title":"Effectiveness and outcomes of assisted outpatient treatment in New York State","volume":"61","author":"Phelan","year":"2010","journal-title":"Psychiatr Serv"},{"key":"S1092852925000045_r3","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1176\/appi.ps.201500073","article-title":"Implementation status of assisted outpatient treatment programs: a national survey","volume":"67","author":"Meldrum","year":"2016","journal-title":"Psychiatr Serv"},{"key":"S1092852925000045_r7","unstructured":"7. American Psychiatric Association. Position statement on involuntary outpatient commitment and related programs of assisted outpatient treatment December 2020. Accessed August 19, 2024. https:\/\/www.psychiatry.org:443\/about-apa\/policy-finder\/position-statement-on-involuntary-outpatient-commi"},{"key":"S1092852925000045_r8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/1039856220924319","article-title":"Life, liberty and the therapeutic relationship: examining the place of compulsory treatment in modern psychiatry","volume":"29","author":"Hegarty","year":"2021","journal-title":"Australas Psychiatry"},{"key":"S1092852925000045_r4","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1176\/appi.ps.52.9.1198","article-title":"Mandated community treatment: beyond outpatient commitment","volume":"52","author":"Monahan","year":"2001","journal-title":"Psychiatr Serv"}],"container-title":["CNS Spectrums"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1092852925000045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T07:47:51Z","timestamp":1742456871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1092852925000045\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025]]}},"alternative-id":["S1092852925000045"],"URL":"https:\/\/doi.org\/10.1017\/s1092852925000045","relation":{},"ISSN":["1092-8529","2165-6509"],"issn-type":[{"value":"1092-8529","type":"print"},{"value":"2165-6509","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e17"}}